Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Shimizu H et al. Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets. 2000 Endocr. J. pmid:11036869
Okajima F et al. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I. 2009 Endocr. J. pmid:18753704
Asghar MY et al. Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. 2012 Endocr. Relat. Cancer pmid:22889737
Balthasar S et al. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. 2008 Endocr. Relat. Cancer pmid:18509004
Kalhori V et al. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion. 2016 Endocr. Relat. Cancer pmid:26935838
Ozbay T et al. ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism. 2004 Endocr. Res. pmid:15666826
Majumdar I and Mastrandrea LD Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. 2012 Endocrine pmid:22228496
Okajima F et al. Sphingosine 1-phosphate stimulates hydrogen peroxide generation through activation of phospholipase C-Ca2+ system in FRTL-5 thyroid cells: possible involvement of guanosine triphosphate-binding proteins in the lipid signaling. 1997 Endocrinology pmid:8977407
Jeng YJ et al. Regulation of oxytocin receptor expression in cultured human myometrial cells by fetal bovine serum and lysophospholipids. 2003 Endocrinology pmid:12488330
Ota K et al. TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts. 2013 Endocrinology pmid:23861379
Grey A et al. The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase. 2002 Endocrinology pmid:12446603
Laychock SG et al. Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet beta-cells. 2006 Endocrinology pmid:16794003
Bergelin N et al. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2. 2009 Endocrinology pmid:19116345
Ozbay T et al. Cyclic adenosine 5'-monophosphate-dependent sphingosine-1-phosphate biosynthesis induces human CYP17 gene transcription by activating cleavage of sterol regulatory element binding protein 1. 2006 Endocrinology pmid:16306078
Rütti S et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. 2009 Endocrinology pmid:19628574
Kato K et al. Regulation by heat shock protein 27 of osteocalcin synthesis in osteoblasts. 2011 Endocrinology pmid:21427224
Wang Y et al. Epidermal growth factor receptor signaling-dependent calcium elevation in cumulus cells is required for NPR2 inhibition and meiotic resumption in mouse oocytes. 2013 Endocrinology pmid:23787120
Törnquist K et al. Sphingosine derivatives inhibit depolarization-evoked calcium entry in rat GH4C1 cells. 1995 Endocrinology pmid:7588222
Serrano-Sanchez M et al. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2. 2008 Endocrinology pmid:18723875
Gratschev D et al. Sphingosine kinase as a regulator of calcium entry through autocrine sphingosine 1-phosphate signaling in thyroid FRTL-5 cells. 2009 Endocrinology pmid:19797403
Patel SA et al. Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity. 2012 Endocrinology pmid:22989629
Wu WT et al. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. 2005 Endocrinology pmid:15878967
Jun DJ et al. Sphingosine-1-phosphate modulates both lipolysis and leptin production in differentiated rat white adipocytes. 2006 Endocrinology pmid:16973728
Törnquist K et al. Sphingosine 1-phosphate mobilizes sequestered calcium, activates calcium entry, and stimulates deoxyribonucleic acid synthesis in thyroid FRTL-5 cells. 1997 Endocrinology pmid:9322911
Bergelin N et al. S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration. 2010 Endocrinology pmid:20501673
Seol GH et al. Sphingosine-1-phosphate-induced intracellular Ca2+ mobilization in human endothelial cells. 2005 Sep-Dec Endothelium pmid:16410226
Limaye V The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology. 2008 May-Jun Endothelium pmid:18568950
Kasbi-Chadli F et al. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet. 2016 Eur J Nutr pmid:25787885
Brakch N et al. Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. 2010 Eur. Heart J. pmid:19773225
Baranowski M et al. Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner. 2015 Eur. J. Appl. Physiol. pmid:25519954
Radin NS Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? 2001 Eur. J. Biochem. pmid:11168352
Nakajima N et al. Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate. 2000 Eur. J. Biochem. pmid:10971577
Guo C et al. Differential stimulation of proline-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine 1-phosphate. 1998 Eur. J. Biochem. pmid:9826186
Pyne S et al. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. 1996 Eur. J. Biochem. pmid:8647130
Chantrain CF et al. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. 2006 Eur. J. Cancer pmid:16406506
Berg C et al. Platelets induce reactive oxygen species-dependent growth of human skin fibroblasts. 2003 Eur. J. Cell Biol. pmid:14703013
Weis T et al. Sphingosine 1-phosphate (S1P) induces expression of E-selectin and adhesion of monocytes via intracellular signalling pathways in vascular endothelial cells. 2010 Eur. J. Cell Biol. pmid:20656374
Frias MA et al. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia. 2017 Eur. J. Clin. Invest. pmid:27861771
Versmissen J et al. Familial hypercholesterolaemia: cholesterol efflux and coronary disease. 2016 Eur. J. Clin. Invest. pmid:27208892
Hemdan NY et al. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis. 2016 Eur. J. Immunol. pmid:27683081
Eskan MA et al. TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. 2008 Eur. J. Immunol. pmid:18395849
Durand CA et al. The Rap GTPases mediate CXCL13- and sphingosine1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes. 2006 Eur. J. Immunol. pmid:16821235
Park SM et al. Sphingosine-1-phosphate lyase is expressed by CD68+ cells on the parenchymal side of marginal reticular cells in human lymph nodes. 2014 Eur. J. Immunol. pmid:24825162
Jin YZ et al. Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease. 2008 Eur. J. Immunol. pmid:18521956
Ottenlinger F et al. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes. 2016 Eur. J. Immunol. pmid:26683421
Kveberg L et al. Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. 2002 Eur. J. Immunol. pmid:12115604
Weichand B et al. Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration. 2013 Eur. J. Immunol. pmid:23934754
Rieck M et al. Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice. 2017 Eur. J. Immunol. pmid:28198542
Rouach N et al. S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK. 2006 Eur. J. Neurosci. pmid:16553609
Barber SC et al. S1P and LPA trigger Schwann cell actin changes and migration. 2004 Eur. J. Neurosci. pmid:15217370
Pébay A et al. Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. 2001 Eur. J. Neurosci. pmid:11467306
Pébay A et al. Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts. 2001 Eur. J. Neurosci. pmid:11422447
Jee BC et al. Effect of sphingosine-1-phosphate supplementation on follicular integrity of vitrified-warmed mouse ovarian grafts. 2010 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:20674140
Kulinski JM et al. Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. 2016 Eur. J. Pharmacol. pmid:25941085
Hendriks-Balk MC et al. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells. 2009 Eur. J. Pharmacol. pmid:19374869
Milara J et al. Sphingosine-1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis. 2009 Eur. J. Pharmacol. pmid:19285497
Shimamura K et al. Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells. 2004 Eur. J. Pharmacol. pmid:14975703
Meyer zu Heringdorf D et al. Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. 2001 Eur. J. Pharmacol. pmid:11239914
Anjum I et al. Enhancement of S1P-induced contractile response in detrusor smooth muscle of rats having cystitis. 2017 Eur. J. Pharmacol. pmid:28882559
Hornuss C et al. Human and rat alveolar macrophages express multiple EDG receptors. 2001 Eur. J. Pharmacol. pmid:11698050
Liu W et al. Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition. 2016 Eur. J. Pharmacol. pmid:26921757
Young KW et al. Effect of dimethylsphingosine on muscarinic M(3) receptor signalling in SH-SY5Y cells. 2000 Eur. J. Pharmacol. pmid:10940357
Kendig DM et al. Sphingosine-1-phosphate induced contraction of bladder smooth muscle. 2013 Eur. J. Pharmacol. pmid:24120660
Qi X et al. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice. 2010 Eur. J. Pharmacol. pmid:20206620
Anada Y et al. The immunomodulator FTY720 is phosphorylated and released from platelets. 2007 Eur. J. Pharmacol. pmid:17553484
Mo FM et al. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. 2004 Eur. J. Pharmacol. pmid:15063151
Kawashima T et al. Contrary effects of sphingosine-1-phosphate on expression of α-smooth muscle actin in transforming growth factor β1-stimulated lung fibroblasts. 2012 Eur. J. Pharmacol. pmid:23041148
Bradley ME et al. The in vitro metabolism of sphingosine-1-phosphate: identification; inhibition and pharmacological implications. 2011 Eur. J. Pharmacol. pmid:21970805
Salomone S et al. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. 2003 Eur. J. Pharmacol. pmid:12782194
Wang L et al. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. 2011 Eur. Respir. J. pmid:21071472
Liu X et al. Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells. 2016 Exp. Biol. Med. (Maywood) pmid:26376826
Li Y et al. Interaction of cortactin and Arp2/3 complex is required for sphingosine-1-phosphate-induced endothelial cell remodeling. 2004 Exp. Cell Res. pmid:15242766
Kozawa O et al. Sphingosine 1-phosphate regulates heat shock protein 27 induction by a p38 MAP kinase-dependent mechanism in aortic smooth muscle cells. 1999 Exp. Cell Res. pmid:10413591
Moolenaar WH Introduction to the ECR special issue on lysophospholipids in biology. 2015 Exp. Cell Res. pmid:25746723
Newton J et al. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. 2015 Exp. Cell Res. pmid:25770011
Nagata Y et al. Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation. 2014 Exp. Cell Res. pmid:24960577
Wang F et al. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate. 1999 Exp. Cell Res. pmid:10047444
Fieber CB et al. Modulation of total Akt kinase by increased expression of a single isoform: requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells. 2006 Exp. Cell Res. pmid:16527273
Nava VE et al. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. 2002 Exp. Cell Res. pmid:12441135
Moolenaar WH Bioactive lysophospholipids and their G protein-coupled receptors. 1999 Exp. Cell Res. pmid:10579925
Rhee S et al. Promigratory and procontractile growth factor environments differentially regulate cell morphogenesis. 2010 Exp. Cell Res. pmid:19796636
Liu W et al. S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. 2012 Exp. Cell Res. pmid:22406263
Stewart CE et al. Increased tyrosine kinase activity but not calcium mobilization is required for ceramide-induced apoptosis. 1999 Exp. Cell Res. pmid:10413587
Boguslawski G et al. Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response. 2002 Exp. Cell Res. pmid:11900487
Young N and Van Brocklyn JR Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. 2007 Exp. Cell Res. pmid:17376432
Kihara Y et al. Lysophospholipid receptors in drug discovery. 2015 Exp. Cell Res. pmid:25499971
Giacomini MM et al. Epithelial cells utilize cortical actin/myosin to activate latent TGF-β through integrin α(v)β(6)-dependent physical force. 2012 Exp. Cell Res. pmid:22309779
Zeng Y et al. Sphingosine 1-phosphate induced synthesis of glycocalyx on endothelial cells. 2015 Exp. Cell Res. pmid:26364737
Bernhart E et al. Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. 2013 Exp. Cell Res. pmid:23562655
Duan HF et al. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. 2004 Exp. Cell Res. pmid:15265705
Misasi R et al. Prosaposin: a new player in cell death prevention of U937 monocytic cells. 2004 Exp. Cell Res. pmid:15242760
Park HY et al. K6PC-5, a novel sphingosine kinase activator, improves long-term ultraviolet light-exposed aged murine skin. 2008 Exp. Dermatol. pmid:18341573
Jung M et al. Anti-ageing effects of a new synthetic sphingolipid (K6EAA-L12) on aged murine skin. 2011 Exp. Dermatol. pmid:21366697
Thieme M et al. Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation. 2017 Exp. Dermatol. pmid:27574180
Stamer WD et al. Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes. 2009 Exp. Eye Res. pmid:19715693
Kamiya T et al. Role of Ca2+ -dependent and Ca2+ -sensitive mechanisms in sphingosine 1-phosphate-induced constriction of isolated porcine retinal arterioles in vitro. 2014 Exp. Eye Res. pmid:24486793
Swaney JS et al. Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. 2008 Exp. Eye Res. pmid:18687328
Caballero S et al. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. 2009 Exp. Eye Res. pmid:18723015
Gupta VK et al. Focus on molecules: Sphingosine 1 Phosphate (S1P). 2012 Exp. Eye Res. pmid:22001715
Dallalio G et al. Inhibition of human erythroid colony formation by ceramide. 1999 Exp. Hematol. pmid:10390188